-+ 0.00%
-+ 0.00%
-+ 0.00%

Ironwood Pharmaceuticals Affirms FY2026 Sales Guidance of $450.000M-$475.000M

Benzinga·02/25/2026 12:08:03
Listen to the news
Ironwood Pharmaceuticals (NASDAQ:IRWD) affirms FY2026 sales outlook from $450.000 million-$475.000 million to $450.000 million-$475.000 million.